Scientists from The University of Manchester have used stem cell gene therapy to treat a fatal genetic brain disease in mice for the first time.
The method was used to treat Sanfilippo – a fatal inherited condition which causes progressive dementia in children – but could also benefit several neurological, genetic diseases.
Researchers behind the study, published in the journal Molecular Therapy this month, are now hoping to bring a treatment to trial in patients within two years.
Sanfilippo, a currently untreatable mucopolysaccharide (MPS) disease, affects one in 89,000 children in the United Kingdom, with sufferers usually dying in their mid-twenties. It is caused by the lack of SGSH enzyme in the body which helps to breakdown and recycle long chain sugars, such as heparan sulphate (HS). Children with the condition build up and store excess HS throughout their body from birth which affects their brain and results in progressive dementia and hyperactivity, followed by losing the ability to walk and swallow.
Dr Brian Bigger, from the University of Manchester’s Institute of Human Development who led the research, said bone marrow transplants had been used to correct similar HS storage diseases, such as Hurler syndrome, by transplanting normal cells with the missing enzyme but the technique did not work with Sanfilippo disease. This is because monocytes, a type of white blood cell, from the bone marrow, did not produce enough enzyme to correct the levels in the brain.
Dr Bigger said: “To increase SGSH enzyme from bone marrow transplants, and to target it to the cells that traffic into the brain, we have developed a stem cell gene therapy which overproduces the SGSH enzyme specifically in bone marrow white blood cells.
“We have shown that mice treated by this method produce five times the normal SGSH enzyme levels in the bone marrow and 11 per cent of normal levels in the brain.
“The enzyme is taken up by affected brain cells and is enough to correct brain HS storage and neuro inflammation to near normal levels and completely corrects the hyperactive behaviour in mice with Sanfilippo.
“This is extremely exciting and could have huge implications for treatments. We now hope to work to a clinical trial in Manchester in 2015.”
The University of Manchester team is now manufacturing a vector – a tool commonly used by molecular biologists to deliver genetic material into cells – for use in humans and hope to use this in a clinical trial with patients at Central Manchester University Hospital NHS Foundation Trust by 2015.
The stem cell gene therapy approach was recently shown by Italian scientists to improve conditions in patients with a similar genetic disease affecting the brain called metachromatic leukodystrophy, with results published in the journal Science earlier this month.
Manchester scientists refined the vector used by the Italian scientists. “This approach has the potential to treat several neurological genetic diseases,” Dr Bigger added.
The Latest Bing News on:
Stem cell gene therapy
- Therapeutic Solutions International Files Patent on "Facilitating Effects" of JadiCells on Gene Therapy Mediated Cell Differentiationon February 26, 2024 at 6:00 am
Therapeutic Solutions International, Inc. (TSOI), announced today data demonstrating that JadiCell administration is capable of increasing gene therapy mediated production of therapeutic cells in vivo ...
- On the Charge: MaxCyte Celebrates Role in Sickle Cell Therapy Breakthroughon February 25, 2024 at 3:59 pm
That therapy, now branded as Casgevy ... during which she got to inspect one of the instruments that featured in the preparation of her gene-edited stem cells, she sat down for an interview with ...
- Technology Insight: Adult Mesenchymal Stem Cells for Osteoarthritis Therapyon February 25, 2024 at 3:59 pm
Targeted gene therapy might further enhance these activities ... His main focus is the development of stem-cell-based technologies for the repair of articular cartilage and bone defects, but ...
- Stem Cells Newson February 23, 2024 at 4:00 pm
How Gene Activity Modulates the Amount of Immune ... shortens the lifespan of patients. The work ... Novel Stem Cell Therapy Using Technology from mRNA COVID-19 Vaccines May Stimulate Natural ...
- New sickle cell therapy using gene-editing offers hope for a cure for a Georgetown womanon February 22, 2024 at 4:01 pm
The trail would alter her stem cells to make more red blood cells without the damaged version that causes terrible symptoms. It uses gene-editing CRISPR technology similar to a therapy recently ...
- Teen says he's 'doing great' after undergoing experimental sickle cell treatmenton February 15, 2024 at 9:22 am
Lubin was born with sickle cell disease, a genetic illness that causes abnormal 'C'-shaped red blood cells that clog blood flow, causing severe pain episodes and organ damage. More than two years ago, ...
- Controversies in Treatment Approaches: Gene Therapy, IVF, Stem Cells, and Pharmacogenomicson February 14, 2024 at 10:59 am
Beyond gene therapy, another issue of much debate relates to the use of stem cells. These cells can be divided into two broad classes: embryonic and adult. Both classes are currently being ...
- Cell and Gene Therapy 2024on February 8, 2024 at 10:13 am
Join us for the second annual Cell and Gene Therapy online symposium, where expert speakers will discuss the current therapeutic landscape, covering ground-breaking research in cancer immunotherapy, ...
- Stem Cell Research and Therapy Newson December 13, 2023 at 4:01 pm
MDedge News, December 18, 2023 EU Conditional Approval: Gene Editor to Treat Blood Diseases The single-dose therapy involves treating and editing patient stem cells ex vivo, then reinfusing them.
The Latest Google Headlines on:
Stem cell gene therapy
[google_news title=”” keyword=”stem cell gene therapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
- Many parents of kids with rare diseases fight for research — even if it’s too late for their childon February 28, 2024 at 2:20 am
Parents of children with rare disease want clinical trials to save their children. Many become advocates. Even if they die, participating in research adds meaning.
- Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlightson February 27, 2024 at 6:05 am
Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for the treatment of ...
- michelle L. sanfilippoon February 21, 2024 at 4:00 pm
michelle L. sanfilippo's office is located at Duke Neurological Disorders Clinic, Durham, NC. View the map. A physician assistant works under the supervision of a medical doctor, providing support ...
- GC Biopharma Presents Updates on its LSD Treatments at the WORLDSymposium 2024on February 14, 2024 at 12:33 am
Recent updates on its development of LSD treatments were presented YONGIN, South Korea, Feb. 14, 2024 /PRNewswire/ -- GC Biopharma (CEO, Eun-Chul Huh), a South Korean biopharmaceutical company, ...
- GC Biopharma Presents Updates on its LSD Treatments at the WORLDSymposium 2024on February 13, 2024 at 4:33 pm
The company's presentation also included posters on non-clinical results of 'GC1130A', a treatment for Sanfilippo syndrome type A (MPS IIIA), and GC1134A/ HM15421, a treatment for Fabry disease.
- Ultragenyx’s Gene Therapy Ameliorates Pediatric Neurodegenerative Disorderon February 6, 2024 at 4:00 pm
“But in a disorder like MPS IIIA, also known as Sanfilippo syndrome type A, the main clinical manifestations are neurologic and cognitive.” Lau then joined her MPS mentor and colleague Emil ...
- Ultragenyx’s gene therapy UX-111 significant for Sanfilippoon February 5, 2024 at 4:01 pm
A disease-modifying gene therapy for Sanfilippo syndrome type A has demonstrated reductions in heparin sulfate within cerebrospinal fluid, as well as increases in the cognitive function of young ...
- The FDA is failing children with a rare, neglected disease sometimes called "childhood dementia"on January 17, 2024 at 2:45 am
The effects of Sanfilippo syndrome in small children are so devastating that the rare disease is often known as "childhood dementia." About one in 70,000 newborns inherit this disorder.
- The FDA is failing children with a rare, neglected disease sometimes called "childhood dementia"on January 16, 2024 at 4:01 pm
The effects of Sanfilippo syndrome in small children are so devastating that the rare disease is often known as "childhood dementia." About one in 70,000 newborns inherit this disorder. The affected ...
- Seattle family spreads awareness of Sanfilippo syndrome, known as childhood Alzheimer'son February 28, 2023 at 2:27 pm
This year, it has special significance for a Seattle family whose son was just diagnosed with a rare disease called Sanfilippo syndrome. They had to fight to get that diagnosis, and now they're ...
The Latest Google Headlines on:
[google_news title=”” keyword=”Sanfilippo disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]